FDA re-examines safety of Parkinson's drug suspected in hundreds of deaths

The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.

Comments

Popular posts from this blog

How to tip The Verge: secure email, Signal, SecureDrop, and more

The New York Attorney General’s Office will investigate the Capital One data breach

Googlers are calling Congress to end forced arbitration